2008
DOI: 10.1016/j.imbio.2007.09.016
|View full text |Cite
|
Sign up to set email alerts
|

MCS-18, a novel natural product isolated from Helleborus purpurascens, inhibits dendritic cell activation and prevents autoimmunity as shown in vivo using the EAE model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
15
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 34 publications
2
15
0
Order By: Relevance
“…One encouraging study showed that inducing liver regulatory DCs by administering Toll-like receptor agonists could lead to the remission of autoimmune disease. 137 These liver tolerogenic mechanisms may also be useful in preventing transplant rejection. 138,139 Thus, tolerization by liver APCs may be an effective approach to prevent antigen-specific allograft rejection and cure autoimmune disease.…”
Section: Future Directionsmentioning
confidence: 99%
“…One encouraging study showed that inducing liver regulatory DCs by administering Toll-like receptor agonists could lead to the remission of autoimmune disease. 137 These liver tolerogenic mechanisms may also be useful in preventing transplant rejection. 138,139 Thus, tolerization by liver APCs may be an effective approach to prevent antigen-specific allograft rejection and cure autoimmune disease.…”
Section: Future Directionsmentioning
confidence: 99%
“…It was also proved that MCS-18 induces a long-lasting suppressive effect and is able to inhibit the expression of typical molecules of mature dendritic cells (DC). This compound impeded the formation of the typical DC/T-cell clusters, which are essential to induce potent immune responses [94]. Another paper that supported the above mentioned facts, added that MCS-18 also reduced B-cell proliferation and immunoglobulin production [95].…”
Section: Immunomodulatory Activitymentioning
confidence: 92%
“…Using EAE assay in vitro as well in vivo the authors were able to show that MCS-18 exerts a strong immunosuppressive activity with remarkable potential for the therapy of diseases characterized by a pathologically over-activated immune system. They concluded that MCS-18 is an efficient modulator of immune response in vitro and in vivo and that is able to inhibit the disease symptoms at different stages [94]. The authors demonstrated that MCS-18 has a very potent non-toxic immune-suppressive activity and their results were strongly supported by clinical trial data reporting that MCS-18 is a highly effective drug in the treatment of arthritis.…”
Section: Immunomodulatory Activitymentioning
confidence: 93%
“…MCS-18, which chemically is classified as a macrocyclic carbon suboxide (C3O2)n derivative in analogy to polyketides defined on their turn as polymers of the "ketide" unit (H2C C O)n, has been prepared as previously described [15]. Shortly: 1 kg of dried and hexane-defatted roots of H. purpurascens (i.e.…”
Section: Mcs-18mentioning
confidence: 99%
“…Thus, the use of pure natural products, such as MCS-18, represents an interesting new strategy. Preclinical investigations have already shown the efficacy of MCS-18 in anti-inflammatory and autoimmune disease models, including the EAE-model [15]. Using this model it could be shown that MCS-18 prevents and/or reduces paralyses symptoms.…”
Section: Introductionmentioning
confidence: 99%